▼ 0.93%
prev close
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Congressional Trades
5
All tracked trades
Members Trading
3
Unique members
Net Activity
-3
1 buys · 4 sells
Members Who Traded This Stock
5 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-09-11 | SNYSanofi - American Depositary Shares | Sell | $1,001 - $15,000 | 162d ago | — | |
| 2025-08-04 | SNYSanofi - American Depositary Shares | Buy | $1,001 - $15,000 | 202d ago | — | |
| 2025-07-22 | SNYSanofi - American Depositary Shares | Sell | $1,001 - $15,000 | 232d ago | — | |
| 2024-09-04 | SNYSanofi - American Depositary Shares | Sell | $1,001 - $15,000 | 573d ago | — | |
| 2022-03-16 | SNYSanofi - American Depositary Shares | Sell | $1,001 - $15,000 | 1444d ago | — |
2025-09-11
Lisa McClain
SNY
Amount
$1,001 - $15,000
Filed
162d ago
2025-08-04
Lisa McClain
SNY
Amount
$1,001 - $15,000
Filed
202d ago
2025-07-22
Lisa McClain
SNY
Amount
$1,001 - $15,000
Filed
232d ago
2024-09-04
John James
SNY
Amount
$1,001 - $15,000
Filed
573d ago
2022-03-16
John Rutherford
SNY
Amount
$1,001 - $15,000
Filed
1444d ago
Recent News
Powered by Polygon.io
Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update
Communiqué de presse : Le Rezurock de Sanofi approuvé dans l’UE pour le traitement de la maladie chronique du greffon contre l’hôte
AstraZeneca Strengthens Position In COPD Race With Successful Trials
Communiqué de presse : La formulation sous-cutanée de Sarclisa de Sanofi, administrée via un injecteur portable, est recommandée par le CHMP pour approbation dans l'UE dans le traitement du myélome multiple
NodThera to Participate in April Investor Conferences
Trade Timeline
Congressional activity, newest first
Lisa McClain
2025-09-11 · Sale
$1,001 - $15,000
Lisa McClain
2025-08-04 · Purchase
$1,001 - $15,000
Lisa McClain
2025-07-22 · Sale
$1,001 - $15,000
John James
2024-09-04 · Sale
$1,001 - $15,000
John Rutherford
2022-03-16 · Sale
$1,001 - $15,000